GREY:ICOTF - Post by User
Comment by
SuperMoneyon Oct 29, 2017 8:38pm
75 Views
Post# 26874359
RE:Immune Spin out of lesser assets
RE:Immune Spin out of lesser assetsHey, trumpmaster, the following is your comments posted in July 24, 2017. Now, IMNP got $18 million dollars for the phase 2 trials. Will it be even better for IMNP to survive? As you said, "ICO is the patent holder.." Even if IMNP can not survive in the worst case, ICO will still be able to go forward for its pipeline, won't it?
Please be noted that this is only my opinion. It is not a financial advice. Do your own DD and invest your money wisely. Cheers.
trumpmaster wrote: Immune is spinning out some other assets to focus on the main assets as described below, ICO is the patent holder..GO GO GO...ICO Trump Immune Pharmaceuticals The transaction will allow Immune to become a pure play immuno-inflammation, clinical stage. development company with all resources being allocated to its lead assets, bertilimumab and nano-cyclosporin, with a special interest in Immuno-Dermatology. Immunes core assets are bertilimumab, a first-in-class human monoclonal antibody targeted at eotaxin-1, currently in phase 2 development in bullous pemphigoid and ulcerative colitis, with a planned phase 2 in severe atopic dermatitis, and a proprietary topical nano-cyclosporine for the treatment of atopic dermatitis and of moderate psoriasis. Read more at https://www.stockhouse.com/news/press-releases/2017/07/19/immune-pharmaceuticals-provides-update-on-plan-to-implement-a-spin-off-of#csEdtQk84dDmVjVR.99